Diagnostic capabilities, clinical features, and longitudinal <scp><i>UBA1</i></scp> clonal dynamics of a nationwide <scp>VEXAS</scp> cohortCarmelo Gurnari, Maria Teresa Voso, Monica Bocchia et al.|American Journal of Hematology|2023Cited by 43
Mechanisms of hematopoietic clonal dominance in VEXAS syndromeRaffaella Molteni, Samuele Ferrari, Gregorio Maria Bergonzi et al.|Nature Medicine|2025Cited by 38
Methodology and clinical utility of longitudinal <scp><i>UBA1</i></scp> tracking in <scp>VEXAS</scp> syndromeCarmelo Gurnari, Maria Teresa Voso, Monica Bocchia et al.|British Journal of Haematology|2024Cited by 10
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)Luca Lanino, Vladan Vučinić, Yu‐Hung Wang et al.|Blood|2024Cited by 3
Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndromeMartina Fiumara, Corrado Campochiaro, Gianluca Scorpio et al.|Expert Review of Hematology|2025Cited by 3